Tingsheng Medical Completes Series B+ Financing to Advance Cardiac Electrophysiology Innovations

Recently, Jiangsu TINGSN Technology Co., Ltd. ("TINGSN Technology") completed its B+ round of financing. The amount of financing has not been disclosed yet, and the investor for this round is Jingming Capital.

TINGSN was founded in January 209 by senior scientists in the ultrasound field, cardiologists, and serial entrepreneurs, with its headquarters located in Nanjing, China.

TINGSN Technology focuses on technological innovation in the field of cardiac electrophysiology and structural heart disease through the combined application of imaging, mapping, and ablation energy, aiming to enable more patients with heart disease to receive more effective treatment.